Visant Medical

Visant Medical is a clinical-stage medical device company. The company's LACRIFILL® cross-linked hyaluronic acid tubular occluder received 510(k) clearance from the U.S. Food and Drug Administration in 2022. LACRIFILL is designed to block tear drainage by occluding the lacrimal duct system. It is suitable for patients with dry eye symptoms and can be used for up to six months.